Vimarsana
Biggest News Aggregation in the World

Bio Communications News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bio Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bio Communications Today - Breaking & Trending Today

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluati - Vimarsana News

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluati

Published: September 8, 2022

Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBioThe collaboration continues to build momentum behind LianBio’s leadership in Asia while Nanobiotix remains focused on enrollment globallyPARIS & CAMBRIDGE, Mass....

Source: pharmiweb.com
Related Topics:
United KingdomSouth KoreaLigia Vela ReidBrandon OwensKate McneilPierre Louis GermainYizhe WangElizabeth AndersonCommunications Investor RelationsFrench Financial Markets Authority AutoritLianbio CommunicationsNanobiotix CommunicationsDrug AdministrationExchange CommissionRegulatory NewsNanobiotix PhaseChief Executive OfficerGreater ChinaChoice PhaseNanobiotix StudyFast TrackPrivate Securities Litigation Reform ActAnnual ReportFrench Financial Markets AuthorityBio Communications
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer - Vimarsana News

NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer

Published: September 7, 2022

Regional activation for Nanobiotix pivotal Phase 3 trial in head and neck cancer proceeds as planned with first patient enrolled in Asia by partner LianBio The collaboration continues to build

Source: finanznachrichten.de
Related Topics:
South KoreaLigia Vela ReidBrandon OwensKate McneilKatherine SmithPierre Louis GermainYizhe WangElizabeth AndersonCommunications Investor RelationsFrench Financial Markets Authority AutoritLianbio CommunicationsNanobiotix CommunicationsDrug AdministrationExchange CommissionNanobiotix PhaseChief Executive OfficerGreater ChinaChoice PhaseNanobiotix StudyFast TrackPrivate Securities Litigation Reform ActAnnual ReportFrench Financial Markets AuthorityInvestor RelationsLouis Germain